8-10 | In July 2023, Médecins Sans Frontières (MSF) closed the chapter on one of its longest standing projects in Malawi, launched some 25 years ago in response to the HIV/AIDS epidemic.
7-6 | After four years of caring for patients with multidrug-resistant tuberculosis in Somaliland, Médecins Sans Frontières/Doctors Without Borders (MSF) is handing over its project to the Ministry of Health Development. When nine-year-old Mohamed fell ill, sweating heavily at night and coughing, his mother, Sabah, took him to the nearest hospital. He was misdiagnosed and the drugs he was prescribed had no effect. “He was prescribed some injectable drugs, but they didn’t work,” recalls Sabah. “He was not improving.”
5-17 | Médecins Sans Frontières/Doctors Without Borders (MSF) are pleased that, having shared the results of TB-PRACTECAL, our clinical trial that found a new, safer and more effective six-month oral treatment regimen for multi drug-resistant tuberculosis (MDR-TB), the World Health Organization (WHO) have announced it will update global guidance on treatment. Following the results of MSF’s trial the WHO are now recommending programmatic use of the 6- month BPaLM regimen – comprising bedaquiline, pretomanid, linezolid (600 mg) and moxifloxacin in MDR-TB patients in pla
2-26 | Médecins Sans Frontières (MSF)'s statement on the escalating situation in Ukraine.
2-26 | Médecins Sans Frontières (MSF)'s statement on the escalating situation in Ukraine.
Pages
Do Something
Field worker
I LIKE MSF
